Nowakowski, Grzegorz S.
Feldman, Tatyana
Rimsza, Lisa M.
Westin, Jason R.
Witzig, Thomas E. http://orcid.org/0000-0002-4215-6500
Zinzani, Pier Luigi
Article History
Received: 19 December 2018
Accepted: 8 April 2019
First Online: 16 May 2019
Conflict of interest
: G.S.N. has received research funding from Celgene, Bayer, Morphosys, and Roche; T.F. has served on the speakers’ bureau for and consulted with Seattle Genetics, she has served on the speakers’ bureau for Kite Pharma, Abbvie, Janssen, Pharmacyclics, and Celgene, and has consulted for BMS; L.M.R. is the inventor of the Lymph2Cx assay; T.E.W. has consulted for Spectrum without personal compensation, consulted for Sandoz with personal compensation, and received research funding from Celgene and Novartis; P.L.Z. has consulted with and served on the speakers’ bureau for Celgene, Roche, Janssen, Gilead Bristol-Myers Squibb, Merck, and Servier, and has consulted with Verastem; and J.R.W. has nothing to disclose.